health · HHS-CDC-HHSCDCERA

Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)

Centers for Disease Control and Prevention - ERA · RFA-OH-21-007

Closed

Award Range

$800K – $1.1M

Total Program Funding

$5.5M

Expected Awards

Deadline

March 25, 2021

GRANTQUICK SUMMARYPlain-English Overview

Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24). Centers for Disease Control and Prevention - ERA. The National Mesothelioma Virtual Bank for Translational Research (NMVB) was established in fiscal year 2006 to serve as an exceptional resource for mesothelioma research. RFA-OH-21-007 will continue the NMVB to advance biomedical research for malignant mesothelioma to gain a better understanding... $800,000-$1,100,000 per award; $5,500,000 total program funding; ~1 awards expected.

Who Should Apply

Other eligible entities

Who Should NOT Apply

Individuals and organizations outside the specified eligible types

Key Requirements (Plain English)

•This is a single-eligibility award
•Deadline: 2021-03-25

💡 GrantQuick Tip

High-value award — invest significantly in proposal quality. Consider hiring a grant writer.

Competitiveness: Very high — extremely limited awards available

What This Grant Funds

The National Mesothelioma Virtual Bank for Translational Research (NMVB) was established in fiscal year 2006 to serve as an exceptional resource for mesothelioma research. RFA-OH-21-007 will continue the NMVB to advance biomedical research for malignant mesothelioma to gain a better understanding of the disease and its progression, and the potential development of new treatments, therapeutics, and diagnostics for mesothelioma. Continued support to the NMVB will allow expansion of collection of biospecimens, related data, and other information. NIOSH intends to continue the NMVB at the University of Pittsburgh to accomplish the following important program priorities: maintain uninterrupted assistance to mesothelioma researchers; avoid critical support gaps for current or pending mesothelioma research efforts; demonstrate a sustained public health commitment to advancing the treatment of mesothelioma; and affirm a sustained commitment to workers and other people impacted by this disease.

Attachments

PDF

OH-21-007_Final NOFO_01.25.2021.pdf

OH-21-007_Final_NOFO_01.25.2021.pdf

Who Can Apply

This is a single-eligibility award. Only the University of Pittsburgh, the institution with the existing National Mesothelioma Virtual Bank for Translational Research, is eligible to apply.

Eligible Applicant Types

Other (see NOFO for details)

Funding Details

Minimum Award: $800K
Maximum Award: $1.1M
Total Program Funding: $5.5M
Expected Number of Awards: 1
Cost Sharing Required?: No
Funding Instrument: cooperative_agreement

Key Dates

Posted: January 22, 2021

Application Deadline: March 25, 2021 (0 days remaining)

Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information it contains allows CDC staff to plan the review. By the date listed above and in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information: Name of the Applicant Descriptive title of proposed research Name, address, and telephone number of the PD(s)/PI(s) Names of other key personnel Participating institutions Number and title of this funding opportunity The letter of intent should be sent to: Michael Goldcamp, Ph.D. National Institute for Occupational Safety and Health Centers for Disease Control and Prevention Telephone: 304-285-5951 Email: MGoldcamp@cdc.gov

Agency Contact

BRIDGETTE GARRETT beg8@cdc.gov

beg8@cdc.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov

View on Grants.gov